UK Cystic Fibrosis Registry Annual Data Report 2017

Slides:



Advertisements
Similar presentations
UK Renal Registry 13th Annual Report Figure 12.1: Median height z-scores for transplant patients in 2009.
Advertisements

Lung Function Nutrition FEV 1 Percent Predicted vs BMI Percentiles Patients
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients
UK Renal Registry 17th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2013.
WHAT IS BMI? BMI BODY MASS INDEX- BASED ON HEIGHT AND WEIGHT TO DETERMINE AMOUNT OF FAT AN INDIVIDUAL HAS OBESE BMI > 30.
UK Renal Registry 14th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2010.
實習生 : 中山醫 李佳靜 指導老師 : 陳燕慈 營養師 The Relationship of BMI and Lung Transplant Recipients 1.
UK Renal Registry 17th Annual Report Figure Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.
UK Renal Registry 16th Annual Report Figure Summary of BP achievements.
UK Renal Registry 14th Annual Report Figure Summary of BP achievements.
How to Calculate Your Body Mass Index (BMI)
UK Renal Registry 16th Annual Report Figure Median height z-scores for transplant patients
 Inherited chronic disease that affects the lungs and digestive system  About 30,000 people in the United States are affected – 70,000 worldwide. 
UK Renal Registry 15th Annual Report Figure 7.1. Median height z-scores for transplant patients
USRDS USRDS 2002 adr Incident counts by initial modality figure 7.1 patients age 19 years & younger.
Childhood Obesity by Rajalakshmi Lakshman, Cathy E. Elks, and Ken K. Ong Circulation Volume 126(14): October 2, 2012 Copyright © American Heart.
How to Calculate Your Body Mass Index (BMI)
Brief History in USA & UK
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 15th Annual Report
Summary of the 2013 ERA-EDTA Registry Annual Report
UK Renal Registry 16th Annual Report
UK Renal Registry 18th Annual Report
Effect of dornase alfa on inflammation and lung function: Potential role in the early treatment of cystic fibrosis  Michael W. Konstan, Felix Ratjen 
BMI: Body Mass Index.
HEART-LUNG TRANSPLANTATION
Advances in Cystic Fibrosis Views and Perspectives From Basel, Switzerland, 2016.
UK Renal Registry 13th Annual Report
Infections in Patients with Cystic Fibrosis
UK Renal Registry 11th Annual Report
Assessment of nutritional status in children with cystic fibrosis: conventional anthropometry and bioelectrical impedance analysis. A cross-sectional.
UK Renal Registry 11th Annual Report 2008
Effect of changes in postoperative spirometry on survival after lung transplantation  David P. Mason, MD, Jeevanantham Rajeswaran, MSc, Liang Li, PhD,
Measuring and improving respiratory outcomes in cystic fibrosis lung disease: Opportunities and challenges to therapy  Edith T. Zemanick, J. Kirk Harris,
HEART-LUNG TRANSPLANTATION
UK Renal Registry 13th Annual Report
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
HEART-LUNG TRANSPLANTATION
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Statistical limitations of percent ideal body weight as measure for nutritional failure in patients with cystic fibrosis  T.O. Hirche, H. Hirche, S. Jungblut,
UK Renal Registry 11th Annual Report
UK Renal Registry 16th Annual Report
Advanced glycation end products are elevated in cystic fibrosis-related diabetes and correlate with worse lung function  William R. Hunt, Beth R. Helfman,
HEART-LUNG TRANSPLANTATION
16 serial measurements between 13 and 16 years of age in a boy with Cystic Fibrosis with height measurements at the 2nd centile [28]. % predicted values.
UK Renal Registry 14th Annual Report
A specific database for providing local and national level of integration of clinical data in cystic fibrosis  T. Leal, G. Reychler, P. Mailleux, J. Gigi,
The Latest Intestinal Transplant Data
Changes in weight and body mass index (BMI) associated with quality improvement. Changes in weight and body mass index (BMI) associated with quality improvement.
Association between practice patterns and body mass index percentile in infants and young children with cystic fibrosis  Raj Padman, Lloyd N. Werk, Gabriela.
HEART-LUNG TRANSPLANTATION
Strategies for Infection Control in Cystic Fibrosis
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
UK Renal Registry 12th Annual Report
UK Renal Registry 16th Annual Report
The impact of switching to the new global lung function initiative equations on spirometry results in the UK CF Registry  Sanja Stanojevic, Janet Stocks,
The effect of social deprivation on clinical outcomes and the use of treatments in the UK cystic fibrosis population: a longitudinal study  Dr David C.
Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis  Hanne Vebert Olesen, Uffe Holmskov, Peter Oluf Schiøtz, Grith Lykke Sørensen 
The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation  C. Etherington,
UK Renal Registry 10th Annual Report 2007
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
UK Renal Registry 13th Annual Report
UK Renal Registry 11th Annual Report
Cystic fibrosis and pregnancy in the modern era: A case control study
Gamma camera scans showing posterior lung images of 4 adult patients with cystic fibrosis following inhalation of an aerosol containing the radioisotope.
Using the lambda, mu, sigma method, the sigma and lambda terms allow the 5th percentile lower limit of normal to be independently calculated throughout.
UK Renal Registry 9th Annual Report 2006
Obesity Trends Among U.S. Adults Between 1985 and 2010
HEART-LUNG TRANSPLANTATION
Presentation transcript:

UK Cystic Fibrosis Registry Annual Data Report 2017 Full report can be found at cysticfibrosis.org.uk/registryreports

1.1 Summary of the UK Cystic Fibrosis Registry UK Cystic Fibrosis Registry Annual Data Report 2017

1.2 Age distribution by gender N=9887 UK Cystic Fibrosis Registry Annual Data Report 2017

1.3 Height percentiles of children and young people (<20 years) N=4730 UK Cystic Fibrosis Registry Annual Data Report 2017

1.4 Weight percentiles of children and young people (<20 years) N=4730 UK Cystic Fibrosis Registry Annual Data Report 2017

1.5 Body Mass Index (BMI) percentiles in children and young people (<20 years) N=4730 UK Cystic Fibrosis Registry Annual Data Report 2017

1.6 Body Mass Index (BMI) in adults (20 years and over) N=5071 UK Cystic Fibrosis Registry Annual Data Report 2017

1.12 FEV1% predicted (GLI equations) in patients aged six years and older who have not had a lung transplant N=8168 UK Cystic Fibrosis Registry Annual Data Report 2017

1.14 FEV1% predicted (GLI equations) over time in patients six years and older who have not had a lung transplant N=8168 in 2017, N=7268 in 2013, N=5049 in 2008* UK Cystic Fibrosis Registry Annual Data Report 2017

1.15 FEV1% predicted (GLI equations) and BMI in people aged 20 years and over who have not had a transplant N=4764 UK Cystic Fibrosis Registry Annual Data Report 2017

1.16 Lung infections in 2017 N=9887 UK Cystic Fibrosis Registry Annual Data Report 2017

1.19 Lung infections over time N=6082 in 2008, N=9052 in 2013, N=9887 in 2017 UK Cystic Fibrosis Registry Annual Data Report 2017

1.36 Median predicted survival age UK Cystic Fibrosis Registry Annual Data Report 2017

1.37 Age distribution of deaths in 2017 UK Cystic Fibrosis Registry Annual Data Report 2017